Matches in Wikidata for { <http://www.wikidata.org/entity/Q82566041> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q82566041 description "artículu científicu espublizáu n'avientu de 2011" @default.
- Q82566041 description "im Dezember 2011 veröffentlichter wissenschaftlicher Artikel" @default.
- Q82566041 description "scientific article published on 01 December 2011" @default.
- Q82566041 description "wetenschappelijk artikel" @default.
- Q82566041 description "наукова стаття, опублікована в грудні 2011" @default.
- Q82566041 name "Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration" @default.
- Q82566041 name "Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration" @default.
- Q82566041 type Item @default.
- Q82566041 label "Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration" @default.
- Q82566041 label "Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration" @default.
- Q82566041 prefLabel "Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration" @default.
- Q82566041 prefLabel "Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration" @default.
- Q82566041 P1433 Q82566041-089E20DD-BC24-4F2B-B92D-9C362C3DF9A5 @default.
- Q82566041 P1476 Q82566041-6761D2F8-243C-460D-A05B-4F7FD69FE7CF @default.
- Q82566041 P2093 Q82566041-0BA01C5E-1EDB-4B90-9DFE-0EB103171202 @default.
- Q82566041 P2093 Q82566041-4E873158-6FCF-4C8E-8707-4E40A74E9AA6 @default.
- Q82566041 P2860 Q82566041-6ADEEA69-CCCD-4BE1-A705-40476101132B @default.
- Q82566041 P2860 Q82566041-C81D8504-3389-4581-B80A-EC6817005E1F @default.
- Q82566041 P2860 Q82566041-F0BFF745-E91C-44A3-B37D-DB27833236A7 @default.
- Q82566041 P304 Q82566041-3325D5BF-F29C-4334-8A67-5CF102CC6DD2 @default.
- Q82566041 P31 Q82566041-98D48F16-315A-4E35-86B2-9AC53F97E825 @default.
- Q82566041 P356 Q82566041-B3E51683-57D1-4043-884A-099D1B80D3D0 @default.
- Q82566041 P433 Q82566041-517A5677-9EB8-494F-959E-16D4A6330184 @default.
- Q82566041 P478 Q82566041-CF7CE3B8-CAE6-40DA-B61C-0F6AF90DC9ED @default.
- Q82566041 P50 Q82566041-2D6EC747-B0DF-4C67-8EA5-850FA402C57A @default.
- Q82566041 P50 Q82566041-7805ADDC-75D1-4C0E-9F8B-E71A328A924F @default.
- Q82566041 P577 Q82566041-5F1BD4A5-D520-453D-918C-C2FFBEA313C7 @default.
- Q82566041 P698 Q82566041-8767AAC7-23E1-4DE4-B9F0-4777A58CBD53 @default.
- Q82566041 P921 Q82566041-54D67AFA-D8B7-47D5-88DC-2CE4795054EC @default.
- Q82566041 P356 AJHP100663 @default.
- Q82566041 P698 22095816 @default.
- Q82566041 P1433 Q15754037 @default.
- Q82566041 P1476 "Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration" @default.
- Q82566041 P2093 "Pamela R Tessier" @default.
- Q82566041 P2093 "Seth T Housman" @default.
- Q82566041 P2860 Q34699108 @default.
- Q82566041 P2860 Q37388282 @default.
- Q82566041 P2860 Q51542067 @default.
- Q82566041 P304 "2265-2270" @default.
- Q82566041 P31 Q13442814 @default.
- Q82566041 P356 "10.2146/AJHP100663" @default.
- Q82566041 P433 "23" @default.
- Q82566041 P478 "68" @default.
- Q82566041 P50 Q117238804 @default.
- Q82566041 P50 Q97634314 @default.
- Q82566041 P577 "2011-12-01T00:00:00Z" @default.
- Q82566041 P698 "22095816" @default.
- Q82566041 P921 Q47495786 @default.